FDA Orange Book
Generic for Xanax XR
Xanax XR contains alprazolam. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Xanax XR is alprazolam. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Xanax XR and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Xanax XR products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, extended release, oral | 0.5MG | Marketed (Rx) | AB | 2 | AB |
| tablet, extended release, oral | 1MG | Marketed (Rx) | AB | 2 | AB |
| tablet, extended release, oral | 2MG | Marketed (Rx) | AB | 2 | AB |
| tablet, extended release, oral | 3MG | Marketed (Rx) | AB | 2 | AB |
NDA 021434, held by UPJOHN US 2 LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic alprazolam
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| AMNEAL PHARMACEUTICALS NY LLC | 078387 | AB (A-rated, therapeutically equivalent) | May 30, 2008 | 0.5MG, 1MG, 2MG, 3MG |
| AUROBINDO PHARMA LTD | 090871 | AB (A-rated, therapeutically equivalent) | June 7, 2011 | 0.5MG, 1MG, 2MG, 3MG |
Xanax XR NDC codes
Questions
Is there a generic for Xanax XR?
Yes. The generic name for Xanax XR is alprazolam. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Xanax XR?
The active ingredient in Xanax XR is alprazolam, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.